Douglas Bootle

1.6k citations
13 papers · 1.2k · h-index 11

Impact in

  • Oncology top 10%
    • Drug Transport and Resistance Mechanisms
    • Cancer Genomics and Diagnostics
    • Breast Cancer Treatment Studies

Papers in

    • PI3K/AKT/mTOR signaling in cancer 5
    • Cancer therapeutics and mechanisms 2
    • Polyamine Metabolism and Applications 2
    • Cancer Treatment and Pharmacology 1

Douglas Bootle

13 papers receiving 1.2k citations

Peers

Douglas Bootle
Comparison fields: 5 of 69
  • Oncology 353
  • Cancer Research 102
  • Molecular Biology 471
  • Pulmonary and Respiratory Medicine 163
  • Otorhinolaryngology 27
Replace Guorong Yang with:
Guorong Yang China
Lisa Y. Pang United Kingdom
Isao Kinoyama Japan
Maria Serena Roca Italy
F. M. Sirotnak United States
Wen‐Ying Lee Taiwan
Larry M. Weisenthal United States
Gregory John Aune United States
Jin Yang China
Rosalin Mishra United States
Douglas Bootle relative to Guorong Yang China Guorong Yang's profile →
Citations per field
00.5×1.5×2×2.3×
Guorong Yang · 1×
Citations per year

Countries citing papers authored by Douglas Bootle

Since Specialization
Citations

This map shows the geographic impact of Douglas Bootle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Douglas Bootle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Douglas Bootle more than expected).

Fields of papers citing papers by Douglas Bootle

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Douglas Bootle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Douglas Bootle. The network helps show where Douglas Bootle may publish in the future.

Co-authors

The 25 scholars most cited alongside Douglas Bootle, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Douglas Bootle Line = papers co-authored together Douglas Bootle links everyone, so they are left out of the graph.

All Works

13 of 13 papers shown
#Work
1 2018358
2
In vitro and in vivo reversal of P-glycoprotein-mediated multidrug resistance by a novel potent modulator, XR9576.
2001315
3 2018216
4 200980
5 200257
6 200450
7 200147
8
BYL719, a next generation PI3K alpha specific inhibitor: Preliminary safety, PK, and efficacy results from the first-in-human study
201237
9 201429
10 200417
11 202312
12 201411
13 20246

About Douglas Bootle

Douglas Bootle is a scholar working on Molecular Biology, Oncology, Modeling and Simulation, Otorhinolaryngology and Pulmonary and Respiratory Medicine, having authored 13 papers that have together received 1.2k indexed citations. Recurring topics across this work include PI3K/AKT/mTOR signaling in cancer (5 papers), Cancer therapeutics and mechanisms (2 papers), Polyamine Metabolism and Applications (2 papers), Lung Cancer Treatments and Mutations (1 paper), Lymphoma Diagnosis and Treatment (1 paper), Advanced Breast Cancer Therapies (1 paper), Cancer Treatment and Pharmacology (1 paper) and Head and Neck Cancer Studies (1 paper). The work is most often cited by research in Oncology (353 citations), Cancer Research (102 citations), Molecular Biology (471 citations), Pulmonary and Respiratory Medicine (163 citations) and Otorhinolaryngology (27 citations). Douglas Bootle has collaborated with scholars based in Switzerland, United States and Netherlands. Frequent co-authors include Peter Charlton, Wendy Dangerfield, Prakash Mistry, Alistair J. Stewart, Cornelia Quadt, Dejan Juric, Jordi A. Rodon, Howard A. Burris, Jane A. Plumb and Christopher Liddle. Their work appears in journals such as Clinical Cancer Research, Anti-Cancer Drugs, Lung Cancer, Journal of Clinical Oncology and British Journal of Clinical Pharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact